Simons Searchlight
X
  • About Us
    • Our Mission
    • Our Participants
    • Simons Searchlight Staff
    • Community Advisory Committee
    • SFARI Programs
  • Research
    • For Scientists
    • Genes We Study
    • Research Process
    • Data & Biospecimens
    • Participating in Other Languages
    • Research Match
  • News
  • Resources
    • Frequently Asked Questions
    • Outreach Toolkit
    • Newsletters
    • Video Library
    • Publications
    • Navigating Life After a Rare Genetic Diagnosis
    • Resource Links
    • COVID-19
      • COVID-19 Vaccine Statement
      • COVID-19 Infection and NDD
      • Caregiver Support
      • Medical Emergency Card
      • Survey Summary
      • Survey 2 Summary
      • Survey 3 Summary
      • Survey 4 Summary
      • Survey 5 Summary
      • Survey 6 Summary
  • Contact Us
  • Join Us
  • Login
X
">

Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability< /strong> < /h2>

Original research article by R. Asadollahi   et al< /em> . (2013)    < /strong> < /p>

Read the abstract here< /a> . < /p>

This study describes three people with changes in the  MED13L    < /em>gene. Two children had deletions, and the third had three copies (triplication) of the MED13L gene plus one other gene. None of the three changes in the  MED13L    < /em>were inherited from either parent. The three children described in this study had some degree of developmental delay and intellectual differences. One child had moderate intellectual disability, and another had mild learning disabilities. The children also had different types of heart defects and low muscle tone. The authors noted that there is clinical overlap between the features caused by changes in the  MED13L    < /em>gene and 22q11.2 deletion syndrome; both of these conditions are caused by similar biological and molecular mechanisms. < /p>

searchlight
  • About
  • Research process
  • Resources
policies
  • Terms of Use
  • Privacy
  • Study Information
simons foundation
  • SFARI
  • SPARK
  • Spectrum
  • Simons Foundation
support
  • Contact Us
  • Frequently Asked Questions
This page was originally written in English. Simons Searchlight cannot guarantee the accuracy of third-party translations.
Simons Searchlight | © 2023 Simons Foundation
en English
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sudanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
We care about your data, and we'd like to use cookies to give you a smooth browsing experience. Please agree and read more about our privacy policy.AGREE